189 related articles for article (PubMed ID: 32396749)
21. Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies.
Abo-Ashour MF; Eldehna WM; Nocentini A; Ibrahim HS; Bua S; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
Bioorg Chem; 2019 Jun; 87():794-802. PubMed ID: 30978604
[TBL] [Abstract][Full Text] [Related]
22. The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs.
Andreucci E; Biagioni A; Peri S; Versienti G; Cianchi F; Staderini F; Antonuzzo L; Supuran CT; Olivo E; Pasqualini E; Messerini L; Massi D; Lulli M; Ruzzolini J; Peppicelli S; Bianchini F; Schiavone N; Calorini L; Magnelli L; Papucci L
Cancer Lett; 2023 Sep; 571():216338. PubMed ID: 37549770
[TBL] [Abstract][Full Text] [Related]
23. Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells.
Federici C; Lugini L; Marino ML; Carta F; Iessi E; Azzarito T; Supuran CT; Fais S
J Enzyme Inhib Med Chem; 2016; 31(sup1):119-125. PubMed ID: 27142956
[TBL] [Abstract][Full Text] [Related]
24. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
[TBL] [Abstract][Full Text] [Related]
25. Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment.
Krasavin M; Shetnev A; Sharonova T; Baykov S; Kalinin S; Nocentini A; Sharoyko V; Poli G; Tuccinardi T; Presnukhina S; Tennikova TB; Supuran CT
Eur J Med Chem; 2019 Feb; 164():92-105. PubMed ID: 30594030
[TBL] [Abstract][Full Text] [Related]
26. Umbelliferone Decreases Intracellular pH and Sensitizes Melanoma Cell Line A375 to Dacarbazin. Comparison with Acetazolamide.
Puech C; Chatard M; Felder-Flesch D; Prevot N; Perek N
Curr Mol Pharmacol; 2018; 11(2):133-139. PubMed ID: 27894244
[TBL] [Abstract][Full Text] [Related]
27. Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines.
Krasavin M; Shetnev A; Baykov S; Kalinin S; Nocentini A; Sharoyko V; Poli G; Tuccinardi T; Korsakov M; Tennikova TB; Supuran CT
Eur J Med Chem; 2019 Apr; 168():301-314. PubMed ID: 30826507
[TBL] [Abstract][Full Text] [Related]
28. Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression.
Peppicelli S; Bianchini F; Toti A; Laurenzana A; Fibbi G; Calorini L
Cell Cycle; 2015; 14(19):3088-100. PubMed ID: 26496168
[TBL] [Abstract][Full Text] [Related]
29. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.
Drenckhan A; Freytag M; Supuran CT; Sauter G; Izbicki JR; Gros SJ
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1024-1033. PubMed ID: 29865880
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological Inhibition of CA-IX Impairs Tumor Cell Proliferation, Migration and Invasiveness.
Ciccone V; Filippelli A; Angeli A; Supuran CT; Morbidelli L
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340282
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.
Stanica L; Gheorghiu M; Stan M; Polonschii C; David S; Bratu D; Dinischiotu A; Supuran CT; Gheorghiu E
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1079-1090. PubMed ID: 28783982
[TBL] [Abstract][Full Text] [Related]
32. Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight hypoxia-induced tumors.
Queen A; Khan P; Idrees D; Azam A; Hassan MI
Int J Biol Macromol; 2018 Jan; 106():840-850. PubMed ID: 28830777
[TBL] [Abstract][Full Text] [Related]
33. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.
Zandberga E; Zayakin P; Ābols A; Pūpola D; Trapencieris P; Linē A
Cancer Biol Ther; 2017 Aug; 18(8):596-605. PubMed ID: 28665755
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
Mboge MY; Chen Z; Wolff A; Mathias JV; Tu C; Brown KD; Bozdag M; Carta F; Supuran CT; McKenna R; Frost SC
PLoS One; 2018; 13(11):e0207417. PubMed ID: 30452451
[TBL] [Abstract][Full Text] [Related]
35. A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors.
McDonald PC; Chia S; Bedard PL; Chu Q; Lyle M; Tang L; Singh M; Zhang Z; Supuran CT; Renouf DJ; Dedhar S
Am J Clin Oncol; 2020 Jul; 43(7):484-490. PubMed ID: 32251122
[TBL] [Abstract][Full Text] [Related]
36. QSAR study of pyrazolo[4,3-e][1,2,4]triazine sulfonamides against tumor-associated human carbonic anhydrase isoforms IX and XII.
Matysiak J; Skrzypek A; Tarasiuk P; Mojzych M
Comput Biol Chem; 2017 Dec; 71():57-62. PubMed ID: 28964980
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity.
Riemann A; Güttler A; Haupt V; Wichmann H; Reime S; Bache M; Vordermark D; Thews O
Oncol Res; 2018 Mar; 26(2):191-200. PubMed ID: 28631600
[TBL] [Abstract][Full Text] [Related]
38. Targeting CAIX with [
Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
[TBL] [Abstract][Full Text] [Related]
40. Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.
Pucciarelli D; Lengger N; Takacova M; Csaderova L; Bartosova M; Breiteneder H; Pastorekova S; Hafner C
Int J Oncol; 2015 Jul; 47(1):81-90. PubMed ID: 25997619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
